-
-
-
-
-
-
-
Solid Biosciences (SLDB) Tops Q4 EPS by 17c
-
-
-
-
-
-
-
Solid Biosciences advances gene therapy trials across muscle diseases
-
-
-
-
-
-
-
Solid Biosciences licenses capsid technology to Andelyn Biosciences
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)
-
-
-
-
-
-
-
Solid Biosciences receives FDA, Health Canada approval for CPVT gene therapy
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)
-
-
-
-
-
-
-
Solid Biosciences (SLDB) reports inducement grants
-
425,735 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

